CN211610219U - Artificial valve - Google Patents

Artificial valve Download PDF

Info

Publication number
CN211610219U
CN211610219U CN202020106975.3U CN202020106975U CN211610219U CN 211610219 U CN211610219 U CN 211610219U CN 202020106975 U CN202020106975 U CN 202020106975U CN 211610219 U CN211610219 U CN 211610219U
Authority
CN
China
Prior art keywords
valve
leaflet
artificial
edge
annular frame
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202020106975.3U
Other languages
Chinese (zh)
Inventor
徐冠彪
陈冰冰
周玲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai maicuier medical technology partnership (L.P.)
Original Assignee
徐冠彪
陈冰冰
周玲
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 徐冠彪, 陈冰冰, 周玲 filed Critical 徐冠彪
Priority to CN202020106975.3U priority Critical patent/CN211610219U/en
Application granted granted Critical
Publication of CN211610219U publication Critical patent/CN211610219U/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Prostheses (AREA)

Abstract

The utility model provides a prosthetic valve, include: a support member and three leaflets; the support member includes: an annular frame and a coating layer; the annular frame is of a net structure and can deform in the radial direction; the coating layer is arranged on the inner surface of the annular frame, is of a pleated structure and can deform in the radial direction; three valve leaflets are arranged in the support component, each valve leaflet is provided with a plurality of folding parts, and all the folding parts stretch along with the radial deformation of the support component. The artificial valve of the utility model can be radially expanded to adapt to the growth of patients; when the radial expansion ratio of the valve is 0-40%, the functionality of the artificial valve can still be ensured, the operation scheme that the artificial valve needs to be replaced again in the prior art is avoided, and the pain of a patient is relieved; when the valve radial expansion ratio is greater than or equal to 40% and less than 100%, the functionality of the prosthetic valve fails, which can serve as an anchoring ring for a re-transcatheter valve replacement procedure.

Description

Artificial valve
Technical Field
The utility model relates to the field of medical equipment, in particular to a prosthetic valve.
Background
Some congenital heart diseases can be combined with right ventricular outflow tract stenosis, the most common of which is Faluo tetrad, which accounts for about 12% -14% of the congenital heart diseases, and the right ventricular outflow tract stenosis needs to be timely surgically corrected. The currently common treatment means include a transvalvular patch dilation procedure, valved conduit replacement. Through the treatment method of surgically implanting the pulmonary valve, as the heart of a patient grows, pulmonary artery stenosis appears first after operation, the pulmonary artery stenosis symptom appears early, and the growth of the heart of an infant patient can be adapted by timely expanding the valve through the saccule, so that the right heart function of the patient is effectively protected. The pulmonary valve regurgitation is generally not caused in early stage due to the compensation of the right heart to the regurgitation, and when a patient is hospitalized again due to symptoms such as chest distress and shortness of breath, the right ventricle is easy to irreversibly hypertrophy and even the right heart failure due to long-term regurgitation, and the treatment can be remedied by secondary thoracotomy or catheter pulmonary valve replacement and other methods, but the curative effect is greatly reduced due to the fact that the right heart function of the patient is seriously affected.
SUMMERY OF THE UTILITY MODEL
In view of the above-mentioned shortcomings of the prior art, it is an object of the present invention to provide a prosthetic valve for solving the above-mentioned problems in the prior art.
In order to solve the above technical problem, the utility model provides a prosthetic valve, include: a support member and three leaflets;
the support member includes: an annular frame and a coating layer;
the annular frame is of a net structure and can deform in the radial direction;
the coating layer is arranged on the inner surface of the annular frame, is of a pleated structure and can be radially deformed;
the three valve leaflets are arranged inside the support component, each valve leaflet is provided with a plurality of folding parts, all the folding parts stretch along with the radial deformation of the support component, the edge of each valve leaflet comprises a fixed edge and a free edge which are connected, and the fixed edge is connected with the support component.
Preferably, the valve radial expansion ratio of the artificial valve is 0-100%; the valve expansion difference divided by the initial valve maximum diameter multiplied by 100% equals the valve radial expansion ratio; the maximum diameter of the initial valve is the outer diameter of the artificial valve in an initial state after being assembled; the valve expansion difference is the difference of the outer diameter of the expanded artificial valve minus the maximum diameter of the initial valve;
when the valve radial expansion ratio of the artificial valve is 0-40%, the artificial valve can realize normal working function.
Further, all of the folds are provided on the leaflets extending to the fixed edge and the free edge.
Further, each of the leaflets includes a fixed lobe and a telescopic lobe connected in series, and all of the folds extend to the fixed edge and the free edge of the telescopic lobe.
Further, each of the pleats extends onto a free edge of the leaflet.
Preferably, the cladding comprises a plurality of cladding elements connected in series; the whole body of each cladding element is of a pleated structure capable of being folded into a wave shape; or each cladding element comprises a fixed cladding piece and a telescopic cladding piece which are sequentially connected, and the telescopic cladding piece is provided with a pleated structure which can be folded into a wave shape.
Preferably, the outer surface of the annular frame is provided with the coating layer.
Preferably, the net structure of the ring frame is provided with rhombic meshes, the rhombic meshes are arranged in more than two rows, and the number of the rhombic meshes is increased from top to bottom.
The utility model discloses still relate to the manufacturing approach of artificial valve, the support component with three after the leaflet is connected the equipment is accomplished to the artificial valve, the external diameter of artificial valve does initial valve maximum diameter.
The utility model also relates to a manufacturing method of the artificial valve, after the supporting component is connected with the three valve leaflets, the artificial valve is pressed and held by a pressing and holding machine, the assembly of the pressed and held artificial valve is completed, and the outer diameter of the pressed and held artificial valve is the maximum diameter of the initial valve;
when the radial expansion ratio of the valve leaflets of the artificial valve is 0-40%, the valve leaflets of the artificial valve can realize normal working function;
the leaflet expansion difference divided by the initial leaflet edge diameter multiplied by 100% equals the leaflet radial expansion ratio;
the diameter of the initial valve leaflet edge is the diameter of a circular area surrounded by the fixed edges of the three valve leaflets after the artificial valve is assembled; the leaflet expansion difference value is equal to the difference value of the diameter of a circular area surrounded by the fixed edges of the three expanded leaflets minus the initial leaflet edge diameter;
dividing the difference value of the valve edges before and after crimping by the quotient of the initial leaflet edge diameter multiplied by 100% to be equal to the leaflet crimping contraction ratio, wherein the difference value of the valve edges before and after crimping is equal to the diameter of a circular area surrounded by the fixed edges of the three leaflets before crimping minus the initial leaflet edge diameter;
when the leaflet crimping contraction ratio is equal to 40%, the wrinkled part is formed on the crimped leaflet;
when the valve leaf is pressed and held with the contraction ratio less than 40%, the folded part is formed on the pressed valve leaf, and a folding part is arranged on the fixed edge of each valve leaf.
As mentioned above, the artificial valve of the utility model has the following beneficial effects:
in the artificial valve of the utility model, the annular frame is a netlike structure which can deform radially; the wrapping layer is provided with a pleated structure which can deform in the radial direction; each valve leaf is provided with a plurality of folding parts; the artificial valve of the utility model can be radially expanded to adapt to the growth of the patient; when the radial expansion ratio of the valve is 0-40%, the functionality of the artificial valve can still be ensured, the operation scheme that the artificial valve needs to be replaced again in the prior art is avoided, and the pain of a patient is relieved; when the valve radial expansion ratio is greater than or equal to 40% and less than 100%, the functionality of the prosthetic valve fails, which can act as an anchoring ring for a re-transcatheter valve replacement, i.e., the prosthetic valve provides effective radial support for a secondarily implanted transcatheter valve in the future, while also acting as a secondarily implanted transcatheter replacement valve itself.
Drawings
Fig. 1 is a perspective view of the prosthetic valve of example 1 in an initial state.
Fig. 2 is a schematic perspective view of the valve prosthesis of example 1 after expansion and with a radial expansion ratio of less than 40%.
Fig. 3 is a schematic perspective view of the valve of example 1 after expansion and when the radial expansion of the valve reaches 100%.
Fig. 4 is an exploded perspective view of the prosthetic valve of example 1 in its initial state.
Fig. 5 is a perspective view of the ring-shaped frame of the prosthetic valve of example 1 in an initial state.
Fig. 6 is a schematic perspective view of the ring-shaped frame of the prosthetic valve of example 1 after expansion and with a radial expansion ratio of the ring-shaped frame less than 40%.
Fig. 7 is a schematic perspective view of the ring-shaped frame of the prosthetic valve of example 1 after expansion and when the ring-shaped frame has been radially expanded to 100%.
Fig. 8 is a schematic structural view showing the ring-shaped frame of the prosthetic valve of example 1 in a deployed state.
Fig. 9 is a perspective view of the coating layer of the prosthetic valve of example 1 in an initial state.
Fig. 10 is a schematic perspective view of the coating layer of the prosthetic valve of example 1 after expansion and with a radial expansion ratio of the coating layer of less than 40%.
Fig. 11 is a schematic perspective view of the cover layer of the prosthetic valve of example 1 after expansion and when the cover layer expands radially to 100%.
Fig. 12 is a perspective view of the prosthetic valve of example 1 with three leaflets in their initial state.
Fig. 13 is a schematic perspective view of the prosthetic valve of example 1 after expansion of three leaflets and when the ratio of radial expansion of the leaflets is less than 40%.
Fig. 14 is a schematic view showing the structure of a leaflet of the prosthetic valve of example 1.
Fig. 15 is a schematic view showing the structure of a leaflet of the prosthetic valve of example 2.
Fig. 16 is a schematic view showing the structure of a leaflet of the prosthetic valve of example 3.
Fig. 17 is a schematic view showing the structure of a leaflet of the prosthetic valve of example 3.
Fig. 18 is a schematic structural view of a covering member of the prosthetic valve according to example 4.
Description of the reference numerals
100 valve leaflet
110 fold part
120 fixed blade
130 telescopic vane
140 pleating part
101 fixed edge
102 free edge
200 Ring frame
300 coating layer
310 cladding element
320 pleated structure
311 fixing cover
312 Telescopic cladding
Detailed Description
The following description is provided for illustrative purposes, and other advantages and features of the present invention will become apparent to those skilled in the art from the following detailed description.
Please refer to the attached drawings. It should be understood that the structure, ratio, size and the like shown in the drawings attached to the present specification are only used for matching with the content disclosed in the specification, so as to be known and read by those skilled in the art, and are not used for limiting the limit conditions that the present invention can be implemented, so that the present invention has no technical essential meaning, and any structure modification, ratio relationship change or size adjustment should still fall within the scope that the technical content disclosed in the present invention can cover without affecting the function that the present invention can produce and the purpose that the present invention can achieve. Meanwhile, the terms such as "upper", "lower", "left", "right", "middle" and "one" used in the present specification are for convenience of description, and are not intended to limit the scope of the present invention, and changes or adjustments of the relative relationship thereof may be made without substantial technical changes, and the present invention is also regarded as the scope of the present invention.
As shown in fig. 1 to 14, the prosthetic valve of the present embodiment includes: a support member and three leaflets 100;
the support member includes: a ring frame 200 and a cover 300;
the annular frame 200 is a net structure and can deform radially;
the covering layer 300 is arranged on the inner surface of the ring frame 200, and the covering layer 300 is in a pleated structure 320 and can be radially deformed;
three leaflets 100 are disposed inside the support member, each leaflet 100 is provided with a plurality of folds 110, all folds 110 are stretched with radial deformation of the support member, the edge of each leaflet 100 comprises a fixed edge 101 and a free edge 102, the fixed edge 101 is connected with the support member.
The annular frame 200, the coating 300, and the three leaflets 100 expand and contract in equal proportion.
The valve radial expansion ratio of the artificial valve is 0-100%; the valve expansion difference divided by the initial valve maximum diameter multiplied by 100% equals the valve radial expansion ratio; the maximum diameter of the initial valve is the outer diameter of the artificial valve in an initial state after being assembled; the valve expansion difference is the difference of the outer diameter of the expanded artificial valve minus the maximum diameter of the initial valve;
when the valve radial expansion ratio of the artificial valve is 0-40%, the artificial valve can realize normal working function.
The utility model discloses a prosthetic valve is suitable for the surgery and implants, opens patient's heart through surgery operation and implants, and the surgery is sewed up and is fixed in pulmonary artery native valve ring department or native valve ring top, effectively prevents the palirrhea of pulmonary artery.
In the artificial valve of the present invention, the annular frame 200 is a radially deformable net structure; the wrapping layer 300 is provided with a pleated structure 320 which can deform radially; each leaflet 100 is provided with a plurality of folds 110; the artificial valve of the utility model can be radially expanded to adapt to the growth of the patient; because the maximum working diameter of the artificial valve is 140% of the maximum diameter of the initial valve, when the radial expansion ratio of the valve is 0-40%, the functionality of the artificial valve can be ensured, the operation scheme that the artificial valve needs to be replaced again in the prior art is avoided, and the pain of a patient is relieved; the functionality of the prosthetic valve fails when the valve radial expansion ratio is equal to or greater than 40% and equal to or less than 100%, which can act as an anchoring ring for a second transcatheter valve replacement procedure, i.e. the prosthetic valve provides effective radial support for a second, implanted transcatheter valve in the future, while also acting as a second, implanted transcatheter replacement valve itself. The artificial valve of the utility model can also be combined with a pipeline to be used as a novel pipeline with valve.
The outer surface of the ring frame 200 is provided with the coating layer 300. The inner and outer surfaces of the ring frame 200 are provided with the structure of the coating layer 300, so that the structure of the supporting member is more stable.
The cladding 300 is a complete structure or the cladding 300 comprises a plurality of cladding elements 310 connected in sequence; in this embodiment, the covering 300 comprises a plurality of covering elements 310 connected in sequence, and the entirety of each covering element 310 is a pleated structure 320 capable of being folded into a wave shape. The structure is convenient to process and stretch.
In this embodiment, the two coating layers 300 are divided into an inner coating layer 300 and an outer coating layer 300, the inner coating layer 300 is tightly attached to the inner side of the ring frame 200, and the outer coating layer 300 is tightly attached to the outer layer of the ring frame 200. The coating layer 300 is a closed circular ring formed by a plurality of waves, the coating layer 300 can be radially expanded and deformed, and the wavy pleated structure 320 gradually changes into a circular arc structure in the process of expanding the coating layer 300. The coating layer 300 at the inner layer and the coating layer 300 at the outer layer are connected with the ring frame 200 by sewing threads, and the fixing feature is that the coating layer 300 is fixed in a wave shape.
The radial expansion ratio of the coating layer 300 is 0-100%, and the product of the difference between the outer diameter of the expanded coating layer 300 minus the outer diameter of the initial coating layer 300 divided by the outer diameter of the initial coating layer 300 multiplied by 100% is equal to the radial expansion ratio of the coating layer 300. The outer diameter of the initial coating layer 300 is the outer diameter of the coating layer 300 in its initial state after assembly of the prosthetic valve.
When the radial expansion ratio of the coating layer 300 is 100%, all the pleated structures 320 are completely straightened, and the coating layer 300 takes the shape of a circular arc.
The undulating pleated structure 320 is such that upon expansion, the plurality of undulating structures gradually straightens out from a crimped state, with the amplitude of the undulating structures decreasing as the valve radially expands in diameter.
The material of the coating layer 300 can be selected from polyester, polytetrafluoroethylene and other high polymer materials and animal pericardial tissues such as pig, cattle, horse, sheep and the like.
The mesh structure of the ring frame 200 is provided with rhombic meshes, the rhombic meshes are arranged in more than two rows, and the number of the rhombic meshes is increased from top to bottom. The annular frame 200 is expanded by the expansion deformation of all the diamond-shaped meshes. The expansion characteristic of the annular frame 200 is that the mesh at the bottom layer is radially expanded firstly, and when the radial expansion ratio of the annular frame 200 is 0-40%, the diamond mesh at the top layer cannot be expanded; when the equal radial expansion reaches the maximum, all the diamond meshes are expanded.
In this embodiment, the rhombic cells are arranged in three rows, and the number of the rhombic cells is increased from top to bottom in sequence to form a three-row step-shaped closed circular ring structure.
The radial expansion ratio of the ring frame 200 is 0-100%, and the product of the difference between the outer diameter of the ring frame 200 after expansion minus the outer diameter of the ring frame 200 in the initial state divided by the outer diameter of the ring frame 200 in the initial state multiplied by 100% is equal to the radial expansion ratio of the ring frame 200. The outer diameter of the ring frame 200 in the initial state is the outer diameter of the ring frame 200 in the initial state after the assembly of the prosthetic valve.
The material of the ring frame 200 may be selected from cold-processed nickel titanium, stainless steel, and other metal materials.
Each leaflet 100 has the same shape and size, the functionality of the artificial valve is that the artificial valve can realize normal working function, and the functionality of the artificial valve means that the leaflet 100 automatically opens and closes in the contraction and relaxation process of the heart, namely, the complete opening and closing is realized under the action of blood flow.
The fixed edge 101 of each leaflet 100 is attached to the support member by a suture. The fixed edge 101 of the leaflet 100 is fixed to the covering layer 300 in the inner layer by a suture alone, or the fixed edge 101 of the leaflet 100 is fixed to the support member by a suture through the covering layer 300 in the inner layer.
When the radial expansion ratio of the valve leaflets 100 of the artificial valve is 0-40%, the functionality of the artificial valve is satisfied, and within the range of the radial expansion ratio, the three valve leaflets 100 can be completely closed, and blood flow cannot pass through the middle of the valve leaflets 100. The leaflet 100 differential expansion divided by the initial leaflet 100 edge diameter times 100% equals the leaflet 100 radial expansion ratio; when the radial expansion ratio of the valve leaflet 100 of the artificial valve is more than or equal to 40%, the functionality of the artificial valve fails.
The difference of the expansion of the leaflets 100 is equal to the difference of the diameter of the circular area enclosed by the fixed edges 101 of the three leaflets 100 after expansion minus the diameter of the edge of the initial leaflet 100,
the diameter of the edge of the initial valve leaflet 100 is the diameter of a circular area surrounded by the fixed edges 101 of the three valve leaflets 100 in the initial state after the artificial valve is assembled. When manufacturing a leaflet 100 having an initial leaflet 100 with an edge diameter of 12mm, all the folds 110 are provided on the leaflet 100 extending to the fixed edge 101 and the free edge 102. The expansion of the folding part 110 needs to meet the requirement that when the radial expansion ratio of the valve leaflet 100 of the artificial valve reaches 40%, the artificial valve can realize the normal working function.
In the initial state of the leaflet 100, the free edge 102 of the leaflet 100 is curved and the center of the three closed leaflets 100 is in the shape of a small vortex. When the valve leaflets 100 of the artificial valve are expanded to the maximum size capable of realizing the normal working function of the artificial valve and three valve leaflets 100 are in the opening state, the free edges 102 of the valve leaflets 100 are straightened.
In this embodiment, all the folds 110 are provided on the leaflet 100 extending to the fixed edge 101 and the free edge 102. All of the folds 110 form a wave-shaped structure, and the wave-shaped structure of the leaflet 100 is expanded when the leaflet 100 is expanded. The structure is convenient to process and use.
The leaflet 100 material may be pericardial tissue of animals such as pig, cattle, horse, sheep, etc.
The utility model discloses still relate to the manufacturing approach of artificial valve, the support component with three after leaflet 100 connects the equipment is accomplished to the artificial valve, the external diameter of artificial valve does initial valve maximum diameter.
Example 2
As shown in fig. 15, the present embodiment is different from embodiment 1 in that each of the leaflets 100 includes a fixed lobe 120 and a telescopic lobe 130 connected in series, and all of the folds 110 extend to the fixed edge 101 and the free edge 102 of the telescopic lobe 130. All of the corrugations 110 form a wave-shaped structure. The fixed lobe 120 and the telescopic lobe 130 are connected by a suture. This configuration can facilitate the placement of leaflets 100 with various expansion ratios.
Example 3
As shown in fig. 16 and 17, the present embodiment is different from embodiment 1 in that each of the wrinkles 110 extends to the free edge 102 of the leaflet 100.
In the manufacturing method of the artificial valve of the embodiment, after the supporting component is connected with the three valve leaflets 100, the artificial valve is crimped by using a crimping machine, the crimped artificial valve is assembled, and the outer diameter of the crimped artificial valve is the maximum diameter of the initial valve;
when the radial expansion ratio of the valve leaflet 100 of the artificial valve is 0-40%, the valve leaflet 100 of the artificial valve can realize normal working function;
the leaflet 100 differential expansion divided by the initial leaflet 100 edge diameter times 100% equals the leaflet 100 radial expansion ratio;
the diameter of the edge of the initial valve leaflet 100 is the diameter of a circular area surrounded by the fixed edges of the three valve leaflets 100 after the artificial valve is assembled; the difference of the expansion of the valve leaflet 100 is equal to the difference of the diameter of a circular area surrounded by the fixed edges of the valve leaflet 100 after expansion minus the diameter of the initial valve leaflet 100 edge;
the quotient of the difference value of the valve edges before and after crimping divided by the diameter of the initial valve leaflet 100 edge is multiplied by 100% and equals to the ratio of the crimping contraction of the valve leaflet 100, and the difference value of the valve edges before and after crimping equals to the diameter of a circular area enclosed by the fixed edges of the three valve leaflets 100 before crimping minus the diameter of the initial valve leaflet 100 edge;
when the leaflet 100 is crimped to a contraction ratio equal to 40%, the crimped leaflet 100 has the corrugated part 110 formed thereon; as shown in FIG. 16; namely: when manufacturing a valve leaflet with the edge diameter of the initial valve leaflet 100 being 12mm, the diameter of a circular area surrounded by the fixed edges of the three valve leaflets 100 before being crimped is 16.8mm, namely the crimping contraction ratio is equal to 40%, so that the normal working function of the artificial valve can be realized; so that the fixed edge 101 of the leaflet 100 does not need to reserve the pleated portion 140, and the fixed edge 101 of the leaflet 100 can be completely arc-sutured;
when the pinch contraction ratio of the leaflet 100 is less than 40%, the crimped leaflet 100 forms the folding part 110 thereon, and a fixing edge 101 of each leaflet 100 is provided with a folding part 140, as shown in fig. 17, that is: when manufacturing a leaflet having an initial leaflet 100 with an edge diameter of 12mm, a circular area surrounded by the fixed edges of the three leaflets 100 before crimping has a diameter of 15mm, that is, a crimping contraction ratio of less than 40%, and the pleating part 140 corresponds to an expansion range required for compensating for the thickness of the leaflet between 15mm and 16.8 mm.
Example 4
The present embodiment is different from embodiment 1 in that each of the packing elements 310 includes a fixed packing 311 and a telescopic packing 312 connected in sequence, and the telescopic packing 312 is provided with a pleated structure 320 capable of being folded into a wave shape, as shown in fig. 18. The stationary cover 311 and the telescopic cover 312 are connected by a suture. This configuration can facilitate the placement of cover member 310 with a variety of expansion ratios.
To sum up, the utility model effectively overcomes various defects in the prior art and has high industrial utilization value.
The above embodiments are merely illustrative of the principles and effects of the present invention, and are not to be construed as limiting the invention. Modifications and variations can be made to the above-described embodiments by those skilled in the art without departing from the spirit and scope of the present invention. Accordingly, it is intended that all equivalent modifications or changes which may be made by those skilled in the art without departing from the spirit and technical spirit of the present invention be covered by the claims of the present invention.

Claims (8)

1. A prosthetic valve, comprising: a support member and three leaflets (100);
the support member includes: an annular frame (200) and a cladding (300);
the annular frame (200) is of a net structure and can deform in the radial direction;
the coating (300) is arranged on the inner surface of the annular frame (200), and a pleated structure (320) is arranged on the coating (300) and can be radially deformed;
the three valve leaflets (100) are arranged inside the support component, a plurality of fold parts (110) are arranged on each valve leaflet (100), all the fold parts (110) stretch along with the radial deformation of the support component, the edge of each valve leaflet (100) comprises a fixed edge (101) and a free edge (102) which are connected, and the fixed edge (101) is connected with the support component.
2. The prosthetic valve of claim 1, wherein:
the valve radial expansion ratio of the artificial valve is 0-100%; the valve expansion difference divided by the initial valve maximum diameter multiplied by 100% equals the valve radial expansion ratio; the maximum diameter of the initial valve is the outer diameter of the artificial valve in an initial state after being assembled; the valve expansion difference is the difference of the outer diameter of the expanded artificial valve minus the maximum diameter of the initial valve;
when the valve radial expansion ratio of the artificial valve is 0-40%, the artificial valve can realize normal working function.
3. The prosthetic valve of claim 2, wherein: all the folds (110) are arranged on the leaflet (100) extending to the fixed edge (101) and the free edge (102).
4. The prosthetic valve of claim 2, wherein: each leaflet (100) comprises a fixed leaflet (120) and a telescopic leaflet (130) connected in series, all the folds (110) extending onto the fixed edge (101) and the free edge (102) of the telescopic leaflet (130).
5. The prosthetic valve of claim 2, wherein: each of the folds (110) extends onto a free edge (102) of the leaflet (100).
6. The prosthetic valve of claim 1, wherein: the cladding (300) comprises a plurality of cladding elements (310) connected in series;
the entirety of each packing element (310) is of a pleated structure (320) which can be folded into a wave shape; or each wrapping element (310) comprises a fixed wrapping piece (311) and an expansion wrapping piece (312) which are connected in sequence, and a pleated structure (320) capable of being folded into a wave shape is arranged on the expansion wrapping piece (312).
7. The prosthetic valve of claim 1, wherein: the outer surface of the annular frame (200) is provided with the coating layer (300).
8. The prosthetic valve of claim 1, wherein: the net structure of the annular frame (200) is provided with rhombic meshes, the rhombic meshes are arranged in more than two rows, and the number of the rhombic meshes is increased from top to bottom in sequence.
CN202020106975.3U 2020-01-17 2020-01-17 Artificial valve Active CN211610219U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202020106975.3U CN211610219U (en) 2020-01-17 2020-01-17 Artificial valve

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202020106975.3U CN211610219U (en) 2020-01-17 2020-01-17 Artificial valve

Publications (1)

Publication Number Publication Date
CN211610219U true CN211610219U (en) 2020-10-02

Family

ID=72638674

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202020106975.3U Active CN211610219U (en) 2020-01-17 2020-01-17 Artificial valve

Country Status (1)

Country Link
CN (1) CN211610219U (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220105238A1 (en) * 2020-10-07 2022-04-07 St. Jude Medical, Cardiology Division, Inc. Heat Treating to Improve Synthetic Leaflet Motion and Coaptation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220105238A1 (en) * 2020-10-07 2022-04-07 St. Jude Medical, Cardiology Division, Inc. Heat Treating to Improve Synthetic Leaflet Motion and Coaptation

Similar Documents

Publication Publication Date Title
US11872125B2 (en) Prosthetic heart valve
US20220054266A1 (en) Heart valve prosthesis
US20210177587A1 (en) Sealing Structures for Paravalvular Leak Protection
EP2629699B1 (en) Mitral bioprosthesis with low ventricular profile
JP5685183B2 (en) Heart valve device with stent
CN109561961B (en) Artificial valve and artificial valve implantation method
US20190076244A1 (en) Sealing member for prosthetic heart valve
US9895225B2 (en) Collapsible valve prosthesis
US20080091261A1 (en) Implantable valve prosthesis
CN112336498A (en) Mitral valve assembly
US20200229918A1 (en) Novel transcatheter valve replacement device
WO2008030946A9 (en) Prosthetic heart valves, systems and methods of implanting
CN218075337U (en) Mitral valve stent mechanism
CN115252221B (en) Artificial heart valve
CN114028030A (en) Artificial heart valve
US20220008233A1 (en) Self-growing heart valves
CN211610219U (en) Artificial valve
CN110711052A (en) Transcatheter intervention type artificial valve
CN212382790U (en) Heart valve device with anchoring ring
CN113133852A (en) Prosthetic valve and method of making same
CN113545890B (en) Novel transcatheter mitral valve
US20240138977A1 (en) Bendable/adjustable transcatheter valve replacement devices
CN211633744U (en) Transcatheter intervention type artificial valve
WO2023053040A1 (en) Low profile final seal for heart valve prosthesis
JP2024522220A (en) Expandable prosthetic heart valve frame with leaflet support struts

Legal Events

Date Code Title Description
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20211021

Address after: No. 701 Taogan Road, Sheshan Town, Songjiang District, Shanghai, 2010

Patentee after: Shanghai maicuier medical technology partnership (L.P.)

Address before: 200070 room 809, No.1, Lane 888, Gonghexin Road, Jing'an District, Shanghai

Patentee before: Xu Guanbiao

Patentee before: Chen Bingbing

Patentee before: Zhou Ling

TR01 Transfer of patent right